We live in the perverse world of the OTC, where paid pumping and toxic debt fueled dilution are actually valued because they increase volatility which leads to more profit opportunities for day traders.
I think this ticker has the MMs confused because it's acting like an actual stock.
Every person on this management team could pull down $300K - $500K in total annual compensation at a major company. Unlike most mouth breathing CEO's here, they have almost zero incentive to P&D a few million shares at $0.01.
This venture only makes financial sense for them at a much higher valuation. Which is why they are working their butts off to bring in new business.
Still comes with your standard OTC risk, but in this case I don't think the management team is actively trying to screw shareholders.
Just my opinion though. This is the OTC - anything can happen!
News 
Market Data 
Discover 
AI
